《中國(guó)燒傷創(chuàng)瘍雜志》于1989年創(chuàng)刊,是由中華人民共和國(guó)國(guó)家衛(wèi)生健康委員會(huì)主管,中國(guó)醫(yī)師協(xié)會(huì)主辦的國(guó)家級(jí)醫(yī)學(xué)學(xué)術(shù)期刊。本刊內(nèi)容新穎,結(jié)構(gòu)規(guī)范,涉及面廣,實(shí)用性強(qiáng)；普及與提高兼顧,基礎(chǔ)與臨床并重,可供從事燒傷、創(chuàng)傷、潰瘍、整形、美容等相關(guān)學(xué)科的各級(jí)臨床、教學(xué)和科研人員及醫(yī)學(xué)院校學(xué)生閱讀參考。本刊為雙月刊,CN 11-2650/R,ISSN 1001-0726,郵發(fā)代號(hào)82-600。

1 內(nèi)容與欄目

內(nèi)容：研究探討人體生命科學(xué)規(guī)律；報(bào)道人體再生復(fù)原科學(xué)理論及其研究成果；宣傳再生養(yǎng)生保健新理念、新方法；交流燒傷創(chuàng)瘍?cè)偕t(yī)療技術(shù)臨床經(jīng)驗(yàn)；介紹國(guó)內(nèi)外燒傷創(chuàng)瘍領(lǐng)域最新發(fā)展動(dòng)態(tài)；開(kāi)展學(xué)術(shù)交流與爭(zhēng)鳴。

欄目：人體再生復(fù)原科學(xué)與燒傷創(chuàng)瘍論壇；燒傷研究與治療；創(chuàng)傷研究與治療；體表潰瘍研究與治療；整形美容的研究與治療；五官黏膜潰瘍研究與治療；消化系統(tǒng)疾病的研究與治療；皮膚疾病的研究與治療；肛腸疾病的研究與治療；婦科疾病的研究與治療；生命科學(xué)前沿發(fā)展動(dòng)態(tài)等。

本刊歡迎論著、綜述、基礎(chǔ)研究、臨床研究、臨床經(jīng)驗(yàn)、病例報(bào)道、技術(shù)進(jìn)展、會(huì)議報(bào)道等稿件。專(zhuān)家論壇、述評(píng)等稿件主要為約稿。

2 對(duì)來(lái)稿的要求

2.1 文稿

應(yīng)具有科學(xué)性、創(chuàng)新性、邏輯性、實(shí)用性,論點(diǎn)明確,資料真實(shí),數(shù)據(jù)可靠,文字精煉,層次分明,格式規(guī)范,必要時(shí)應(yīng)做統(tǒng)計(jì)學(xué)處理。研究報(bào)告、論著、綜述等文稿一般不超過(guò)5000字 （不包括圖表和參考文獻(xiàn)）,其他文稿限3000字以?xún)?nèi)。

2.2 文題

力求簡(jiǎn)明、醒目,突出文章主題。中文文題一般不超過(guò)20個(gè)漢字,英文文題一般不超過(guò)10個(gè)實(shí)詞。

2.3 作者

作者姓名在文題下按序排列,一般為1～5名,應(yīng)在投稿時(shí)確定。作者單位應(yīng)標(biāo)注于作者下方,注明所在省、市、區(qū)名和郵政編碼。作者應(yīng)是：（1）參與選題和設(shè)計(jì),或參與資料的分析和解釋者；（2）起草或修改論文中關(guān)鍵性理論或其他主要內(nèi)容者；（3）能對(duì)編輯部的修改意見(jiàn)進(jìn)行核修,在學(xué)術(shù)界進(jìn)行答辯,并最終同意該文發(fā)表者。以上三條均需具備。僅參與獲得資金或收集資料者不能列為作者,僅對(duì)科研小組進(jìn)行一般管理者也不宜列為作者。對(duì)文章中的各主要結(jié)論,均必須至少有一位作者負(fù)責(zé)。集體署名的文章必須明確對(duì)該文負(fù)責(zé)的關(guān)鍵人物；其他對(duì)該研究有貢獻(xiàn)者應(yīng)列入志謝部分。作者中如有外籍作者,應(yīng)征得本人同意,并附證明信。

2.4 摘要

論文需附中、英文摘要,采用結(jié)構(gòu)式摘要,必須包括目的 （objective）、方法（methods）、結(jié)果 （results） （應(yīng)給出主要數(shù)據(jù)）、結(jié)論 （conclusion）四部分,各部分冠以相應(yīng)的標(biāo)題。采用第三人稱(chēng)撰寫(xiě),不用“本文” “作者”等主語(yǔ)。中文摘要一般為200～300字,英文摘要為400個(gè)實(shí)詞左右。英文摘要中應(yīng)包括文題、作者姓名 （漢語(yǔ)拼音）、單位名稱(chēng)、所在城市名、國(guó)名及郵政編碼。作者應(yīng)全部列出,作者姓氏漢語(yǔ)拼音首字母應(yīng)大寫(xiě),名字首字母大寫(xiě),復(fù)姓應(yīng)連寫(xiě),例如：王芳、張現(xiàn)娜、諸葛華分別譯為Wang Fang,Zhang Xianna,Zhuge Hua。

2.5 關(guān)鍵詞

論文需標(biāo)引5～8個(gè)關(guān)鍵詞。請(qǐng)盡量使用美國(guó)國(guó)立醫(yī)學(xué)圖書(shū)館編輯的最新版 《Index Medicus》醫(yī)學(xué)主題詞表 （MeSH）內(nèi)所列的詞。關(guān)鍵詞中的縮寫(xiě)詞應(yīng)按MeSH詞表還原為全稱(chēng),如 “HBsAg”應(yīng)標(biāo)引為 “乙型肝炎表面抗原”。關(guān)鍵詞各詞匯之間以分號(hào) “；”間隔,如應(yīng)激性潰瘍；治療,英文為：Stress ulcer；Treatment。英文關(guān)鍵詞前冠以 “ 【Key words】”作為標(biāo)識(shí),各關(guān)鍵詞首字母大寫(xiě)。

2.6 醫(yī)學(xué)名詞

以科學(xué)出版社出版的 《醫(yī)學(xué)名詞》和相關(guān)學(xué)科的名詞為準(zhǔn)。中文藥物名稱(chēng)應(yīng)使用最新版的 《中華人民共和國(guó)藥典》（法定藥物）或衛(wèi)生部藥典委員會(huì)編輯的 《藥品詞匯》（非法定藥物）中所列出的中文名稱(chēng),英文藥物名稱(chēng)則采用國(guó)際非專(zhuān)利藥名,不用商品名。

2.7 圖表

圖表應(yīng)隨文編排,按其在正文中出現(xiàn)的先后順序連續(xù)編碼。每幅圖 （表）應(yīng)冠有中英文圖 （表）題,表題應(yīng)置于其上,圖題應(yīng)置于其下,說(shuō)明性資料應(yīng)置于圖 （表）下方注釋中,圖 （表）中使用的所有非公知公用的縮寫(xiě)應(yīng)在注釋中說(shuō)明。本刊采用三橫線(xiàn)表（頂線(xiàn)、表頭線(xiàn)、底線(xiàn)）,如遇有合計(jì)或統(tǒng)計(jì)學(xué)處理行 （如t值、P值等）,則應(yīng)在該行上面加一條分界線(xiàn)；表內(nèi)數(shù)據(jù)要求同一指標(biāo)有效位數(shù)一致,一般按標(biāo)準(zhǔn)差的1/3確定有效位數(shù)。凡是涉及分子生物學(xué)的論文,必須提供有分子量標(biāo)示的電泳照片圖。照片圖要求有良好的清晰度和對(duì)比度,若刊用人像,應(yīng)征得本人書(shū)面同意,或遮蓋其能被辨認(rèn)出系何人的部分。大體標(biāo)本照片在圖內(nèi)應(yīng)有尺度標(biāo)記。病理照片要求注明染色方法和放大倍數(shù)。圖 （表）中如有引自他刊者,應(yīng)注明出處,并取得版權(quán)許可。

2.8 計(jì)量單位

執(zhí)行GB 3100/3101/3102-1993《國(guó)際單位制及其應(yīng)用/有關(guān)量、單位和符號(hào)的一般原則/（所有部分）量和單位》的有關(guān)規(guī)定,具體可參照中華醫(yī)學(xué)會(huì)雜志社編寫(xiě)的 《法定計(jì)量單位在醫(yī)學(xué)上的應(yīng)用》 （北京：人民軍醫(yī)出版社,2001）。單位名稱(chēng)與單位符號(hào)不可混合使用；組合單位符號(hào)中表示相除的斜線(xiàn)多于1條時(shí)應(yīng)采用負(fù)數(shù)冪形式表示 （如“mg·kg-1·d-1” 不能表示為 “mg/kg/d”或 “mg/kg·d-1”）。

2.9 數(shù)字

執(zhí)行GB/T 15835-2011《出版物上數(shù)字用法》的有關(guān)規(guī)定。公歷世紀(jì)、年代、年、月、日、時(shí)刻和計(jì)數(shù)、計(jì)量均用阿拉伯?dāng)?shù)字。表示百分?jǐn)?shù)的范圍和偏差時(shí),前一個(gè)數(shù)字的百分符號(hào)不能省略,如：5%～95%不能寫(xiě)成5～95%,50.2% ±0.6%不能寫(xiě)成50.2±0.6%。百分符號(hào)和英文字母均需采用Times New Roman字體。附帶尺寸單位的數(shù)值相乘,按下列方式書(shū)寫(xiě)：4 cm×3 cm×5 cm,不能寫(xiě)成4×3×5 cm3。

2.10 統(tǒng)計(jì)學(xué)符號(hào)

根據(jù)GB 3358.1-2009《統(tǒng)計(jì)學(xué)詞匯及符號(hào)》的有關(guān)規(guī)定,統(tǒng)計(jì)學(xué)符號(hào)一律采用斜體書(shū)寫(xiě),書(shū)寫(xiě)時(shí)需特別注意這些字母是英文還是希文、是大寫(xiě)還是小寫(xiě)、字母頂端的標(biāo)記及上下角標(biāo),常用如下：（1）樣本的算術(shù)平均數(shù)用英文小寫(xiě)x,中位數(shù)用英文大寫(xiě)M； （2）標(biāo)準(zhǔn)差用英文小寫(xiě)s； （3） 標(biāo)準(zhǔn)誤用英文小寫(xiě)sx；（4）t檢驗(yàn)用英文小寫(xiě)t； （5）F檢驗(yàn)用英文大寫(xiě)F；（6） 卡方檢驗(yàn)用希文小寫(xiě)χ2； （7） 相關(guān)系數(shù)用英文小寫(xiě)r； （8）自由度用希文小寫(xiě)ν；（9）概率用英文大寫(xiě)P（P值前應(yīng)給出具體檢驗(yàn)值,如t值、χ2值、q值等）； （10） 在判斷統(tǒng)計(jì)學(xué)處理的意義時(shí),應(yīng)給出具體的P值,如：P=0.01,P=0.05,P＜0.01,P＜0.05,等。

2.11 縮略語(yǔ)

文中盡量少用,必須使用時(shí)應(yīng)于首次出現(xiàn)處先使用中文全稱(chēng),然后在括號(hào)中注明中文縮略語(yǔ)或英文全稱(chēng)及其縮略語(yǔ),后兩者間用 “,”分開(kāi) （如該縮略語(yǔ)已公知,也可不注明其英文全稱(chēng)）?？s略語(yǔ)不得移行。

2.12 參考文獻(xiàn)

按GB/T 7714-2015《信息與文獻(xiàn) 參考文獻(xiàn)著錄規(guī)則》采用順序編碼制著錄,依其在文中出現(xiàn)的先后順序用阿拉伯?dāng)?shù)字加方括號(hào)標(biāo)出。參考文獻(xiàn)中的作者,1～3名全部列出,3名以上者加 “等”。外文期刊名稱(chēng)用縮寫(xiě),以 《Index Mdeicus》中的格式為準(zhǔn)；中文期刊用全名。每條參考文獻(xiàn)均需著錄起止頁(yè)碼。參考文獻(xiàn)必須由作者與其原文核對(duì)無(wú)誤。將參考文獻(xiàn)按引用先后順序 （用阿拉伯?dāng)?shù)字標(biāo)出）排列于文末,舉例：

[1]徐榮祥.燒傷治療大全 [M].北京：中國(guó)科學(xué)技術(shù)出版社,2008：123.

[2] Artz CP,Moncrief JA.The treatment of burn[M].Philadelphia：W.B.Saunders Company,1969：22-88.

[3]李杰輝,黃欣,唐乾利,等.MEBT/MEBO治療糖尿病足潰瘍的臨床療效觀察 [J].中國(guó)燒傷創(chuàng)瘍雜志,2016,28（1）：22-25.

[4]Tang QL,Han SS,Feng J,et al.Moist exposed burn ointment promotes cutaneous excisional wound healing in rats involving VEGF and bFGF[J].Mol Med Rep,2014,9 （4）： 1277.

[5]李磊.大面積危重?zé)齻缙谘鲃?dòng)力學(xué)變化及臨床意義的研究 [D].上海：第二軍醫(yī)大學(xué),2014.

2.13 基金項(xiàng)目

論文所涉及的課題如取得國(guó)家或部、省級(jí)以上基金或?qū)俟リP(guān)項(xiàng)目,應(yīng)以 [基金項(xiàng)目]腳注于作者下方,如×××基金項(xiàng)目（××××）,并附基金證書(shū)復(fù)印件或單位科管部門(mén)的證明函。本刊對(duì)基金項(xiàng)目論文、科研成果報(bào)告、學(xué)術(shù)研究述評(píng)予以?xún)?yōu)先發(fā)表。

3 來(lái)稿注意事項(xiàng)

3.1 請(qǐng)登錄本刊網(wǎng)站www.cjbwu.org投稿,初次投稿者,請(qǐng)先在 “作者登錄”處注冊(cè),然后按照提示要求投稿。

3.2 來(lái)稿須注明每位作者姓名、工作單位、地址、電話(huà) （手機(jī)）號(hào)碼和電子郵箱。

3.3 根據(jù) 《著作權(quán)法》,并結(jié)合本刊規(guī)定,來(lái)稿3個(gè)月內(nèi)為稿件審閱期,作者如欲改投他刊,請(qǐng)先與本刊聯(lián)系,切勿一稿兩投。請(qǐng)自留底稿,恕不退稿。

3.4 來(lái)稿一律文責(zé)自負(fù)。依照 《著作權(quán)法》有關(guān)規(guī)定,本刊可對(duì)來(lái)稿做文字修改、刪節(jié)及標(biāo)準(zhǔn)化加工,凡有涉及原意的修改,則將請(qǐng)作者酌定。

3.5 來(lái)稿一經(jīng)接受刊登,由作者親筆簽署“論文版權(quán)授權(quán)書(shū)”后,本刊編輯委員會(huì)有權(quán)以印刷版、光盤(pán)版、電子期刊等形式出版接受刊登的論文,未經(jīng)本刊編輯委員會(huì)同意,該論文任何部分不得轉(zhuǎn)載他處。

3.6 編輯部聯(lián)系方式

地址：北京市朝陽(yáng)區(qū)東大橋路8號(hào)尚都國(guó)際中心A-31層 《中國(guó)燒傷創(chuàng)瘍雜志》編輯部 郵政編碼：100020電話(huà)：010-58701592

Email：periodical@chinaburn.com

網(wǎng)址：www.cjbwu.org

《中國(guó)燒傷創(chuàng)瘍雜志》編輯部

The Chinese Journal of Burns Wounds&Surface Ulcers（The Journal for short）is a state-level,bimonthly medical academic magazine with its first issue in 1989,supervised by National Health Commission of the People'Republic of China and sponsored by the Chinese Medical Doctor Association.The Journal with its innovative and practical contributions involves a wide range of fields such as burns,traumas,ulcers,plastics,cosmetology and other relevant subjects,and is a valuable reference for clinical,teaching and research staff as well as medical students.CN 11-2650/R,ISSN 1001-0726,Issuing code 82-600.

1.Description

Content scope： The contributions should be： exploring the laws of life science in the human body；reporting the theory and its research outcomes of Human Body Regenerative Restoration Science；popularizing new ideas and approaches in regenerative health preservation with regenerative medicine；exchanging the clinical experience of MEBT/MEBO （Moist Exposed Burn Therapy/Moist Exposed Burn Ointment）； introducing the developmental trends in the medical fields of burns,wounds and surface ulcers at home and abroad；promoting academic exchange and discussion.

Column division：Human Body Regenerative Restoration Science and forum of burns wounds&surface ulcers；burn research and treatment； research and treatment of traumatic wounds； research and treatment of plastic and cosmetic surgery；research and treatment of surface ulcerative wounds；research and therapy of mucosal ulcerations of HEENT；research and treatment of disorders in GI system；research and management of Dermatologic disorders；research and management of anorectal disorders； research and management of gynecological diseases；the news of progress in life science,etc.

The contributions on fundamental research in theory,clinical research,clinical experience,case report,technique progress,meeting minutes,expert forum,feature reviews and etc.are welcomed,of which on the expert forum and feature reviews are mainly solicit manuscripts.

2.Uniform Requirements

2.1.Manuscripts

Submissions should be scientific,innovative,logical and practical with clear arguments,authentic material,true and reliable data support,well-organized and uniform structure,and clear and concise language.Statistical management should be involved if necessary.Research reports,works and reviews intended to be published should be a maximum of 5000 words （tables,figures and reference excluded）,and other contributions should be a maximum of 3000 words.

2.2.Title

Should be clear and concise.A Chinese title should be limited to no more than 20 Chinese characters and an English title should be no more than 10 content words.

2.3.Author（s）

Author name（s） should be listed in a sequence below the title.Generally,one to five authors should be included.The working unit（s）of author（s） should be marked below the name line,in which the address detail including province,city,district and postal code should be given.If an E-mail is available,it could be included directly after the working unit（s） in round brackets,i.e.,working unit（E-mail： xx）.All authors should have made substantial contributions to all of the following： （1） the conception and design of the study,or analysis and interpretation of data； （2） drafting or revising the critical theory or other important intellectual contents in the paper； （3） final approval of the version to be submitted.All other contributors who do not meet the criteria for authorship as defined above should be listed in an acknowledgements section.For each main conclusion,there is at least one responsible author.If there is a foreign author included in the authorship,a signed consent formfrom the foreign authorshould be submitted with the manuscript.

2.4.Abstract

Chinese and English abstracts should be offered.The abstracts are required to be in a structured format including four sections：Objective,Methods,Results（presenting main data） and Conclusion.The writing,using third person is preferred and the subjective expressions such as“our paper or the author thinks” should be avoided.The abstracts should be limited to 200-300 Chinese characters and about 400 English content words.In the English abstract,paper title,author name（Pinyin）,name of work place（s） and city of work place,nationality and postal code should be included.All authors should be listed.For the format when including author names,please follow the below format：the first letter of surname in capital letter,the first letter of the given name in capital and others be normal,for instance：Wang Fang,Zhang Xianna,Zhuge Hua.

2.5.Key words

5-8 Key words are required for each contribution.The words listed in MeSH of the latestIndex Medicusedited by American National Medical Library are preferred.The abbreviation should be avoided in key words,i.e.,HBsAg should be written as hepatitis B surface antigen.A semicolon should be used between each key word with its first letter being capitalized,i.e.,Stress ulcer；Treatment.

2.6.Medical terms

Please follow the guidelines ofMedical Termspublished by the Science Publishing Company or choose the related professional terms.The Chinese name of drugs should be based on the latest edition ofChinese Pharmacopoeia（for statutory drugs） or theMedical Glossary（for nonstatutory drugs）issued by The Pharmacopoeia Committee of Health Ministry of PRC.For the English name of drugs,the international non-patented pharmaceutical names should be referred rather than the commercial names.

2.7.Figures and Tables

Should be numbered in the order they appear in the paper.There should be a short title（both in Chinese and English） included in the front of each table and below each figure,and the explanative words should be put just below the table or the figure with the marking word“note：” at the beginning.Additionally,the non-conventionalized abbreviations appeared in the table or the figure should be noted.Table：tables in the submitted manuscript should be three horizontal-line tables（the top line,header line,the bottom line）.If there is any statistical management needed （such ast-test,Pvalue,etc.）,add a horizontal line above the top line.The data listed in the tables should be consistent in terms of significant digits which are generally determined based on 1/3 standard deviation.Figure：the manuscripts with molecular biology involved should be attached with electrophoresis photographs with the molecular weight labeled and with good sharpness and contrast.If pictures of the face are included in the manuscript,a written consent should be obtained,or the identity-related identifiable characteristic（s） should be covered.A specimen photograph should be marked with its size and pathological pictures should be specified with the staining method （s）and the magnification.Please note that it is the responsibility of the author（s） to obtain permission from the copyright holder to republish the figures or tables that have previously been published elsewhere.

2.8.Units of Measurement

Please comply with the GB3100/3101/3102-1993 of theSI Units and Recommendations for the Use of Their Multiples and of Certain Other Units,and for further reference,please refer to theApplication of China Statutory Measurement Units in the Medical Fieldedited by Journal of Chinese Medical Association （Beijing： People's Military Medical Press,2001）.A measurement unit and its unit symbol can't be used indiscriminately.If there were more than one slash expressing division in the compound unit symbols,the expression form of negative power should be applied （for example,mg·kg-1·d-1,rather than mg/kg/d or mg/kg·d-1,is the recommended right form）.

2.9.Numbers

Please comply with theGeneral Rules for Writing Numerals in Public TextsGB/T 15835-2011.The date,time and counting numbers should be listed in Arabic numerals.The percentage scope should be writtenas 5%-95%or 50.2%±0.6%in Times New Roman typeface,and do not omit the first“%”.For the number with units of measurement to multiply,follow the form as 4 cm×3 cm×5 cm.Do not abbreviate as 4×3×5 cm3.

2.10.Statistical symbols

Please comply with the regulations inStatistical Terms and SymbolsGB 3358.1-2009.Following are the written standards for commonly-used symbols： （1） the arithmetic mean of sample asx（English typeface,lowercase） and median asM； （2） standard deviation ass（English typeface,lowercase）； （3） standard error assx（English typeface,lowercase） ； （4）ttest ast（English typeface,lowercase,italic）； （5）Ftest asF（English typeface,capital,italic）； （6） chi-square test asχ2（Greek typeface,lowercase）； （7） related coefficient asr（English typeface,lowercase,italic）； （8） degree of freedom asν（Greek typeface,lowercase,italic）； （9） probability asP（English typeface,capital,italic） ； （10） in the case of evaluating the statistical significance,concretePvalue should be provided,i.e.,P=0.001,P=0.005,P＜0.01,P＜0.05；and etc.

2.11.Abbreviations

Should be avoided as much as possible.Otherwise,the full name of the abbreviation should be used when first appearing in the text and its corresponding Chinese abbreviation,English full name and its English abbreviation should be enclosed by a bracket（if the abbreviation is wellknown,its English full name can be avoided）.One abbreviation should not be broken into two lines.

2.12.References

Please comply with theReference Written RegulationsGB/T7714-2015.References should be denoted numerically and in sequence in the text,using superscript Arabic numerals placed in square brackets.Quote first three authors'names.If there are more than three,then just quote first three names followed by “et al”.Foreign journal names should be abbreviated to standard format listed inIndex Medicus,while the names of Chinese journals should be in full format.Every piece of reference work should enclose the page number range.References should be verified by the authors according to the original papers,and cited in Arabic numerals at the end of the text in the order of its first appearance in the text.See the following examples：

[1]徐榮祥.燒傷治療大全 [M].北京：中國(guó)科學(xué)技術(shù)出版社,2008：123.

[2]Artz CP,Moncrief JA.The treatment of burn[M].Philadelphia： W.B.Saunders Company,1969： 22-88.

[3]李杰輝,黃欣,唐乾利,等.MEBT/MEBO治療糖尿病足潰瘍的臨床療效觀察 [J].中國(guó)燒傷創(chuàng)瘍雜志,2016,28（1）：22-25.

[4]Tang QL,Han SS,Feng J,et al.Moist exposed burn ointment promotes cutaneous excisional wound healing in rats involving VEGF and bFGF[J].Mol Med Rep,2014,9 （4）：1277.

[5]李磊.大面積危重?zé)齻缙谘鲃?dòng)力學(xué)變化及臨床意義的研究 [D].上海：第二軍醫(yī)大學(xué),2014.

2.13.Role of the funding source

All sources of funding should be declared below the working unit line（s） of the author（s）.The funding certificate copy or certificate of author（s）'working unit or department should be attached with the contributions.The contributions with funding source（s） can enjoy a publishing priority in the Journal.

3.Notes

3.1.Please login www.cjbwu.org to submit your manuscript.If you are a new contributor,please firstly register in the entry “for the author”and then follow the instruction to submit the manuscript.

3.2.The contact information,including name,affiliation,address,telephone number（mobile phone number） and email address,should be enclosed for each author.

3.3.According toCopyright Lawand the regulations issued by The Journal,the review period of one contribution is within 3 months from the date the contribution is received.During the period,the authors should contact The Journal in advance if they want to submit the same manuscript to any other journal.The submitted copy of manuscript will not be returned,so please keep a copy of the contribution before delivery.

3.4.The author（s） should bear the full responsibilities of the contributions.According toCopyright Law,The Journal has the right to revise,delete and modify the manuscripts.The author（s） will be informed to make a decision on any modification involving a change of the original meaning,

3.5.Upon acceptance of the contribution,author（s） will be asked to sign a “Paper Copyright Authorization Agreement”.Then,the Journal Editorial Board reserves the right of publishing the contribution in the forms of print,CD-ROM,electronic journal or others,and without the approval of the editorial board,any part of the contribution shall not be republished anywhere.

3.6.Contact

Editorial Department ofThe Chinese Journal of Burns Wounds&Surface Ulcers

Address：F31,Building A,The Spaces International Center,8

Dongdaqiao Rd,Chaoyang District,Beijing 100020,China.

Post code：100020

Tel： （86） 010-58701592

Email：periodical@chinaburn.com

Website：www.cjbwu.org